![Michal Ayalon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michal Ayalon worked as Vice President of Research and Development at Kamada Ltd. from 2019 to 2022.
Prior to that, she held the same position at Galmed Pharmaceuticals Ltd. in 2015-2016.
In 2018-2019, she was Head of Research and Development at 89Bio Ltd. Ayalon received her undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Tidigare kända positioner av Michal Ayalon
| Företag | Position | Slut |
|---|---|---|
| KAMADA LTD. | Teknisk/Vetenskaplig/F&U Direktör | 2022-02-28 |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Teknisk/Vetenskaplig/F&U Direktör | 2019-01-01 |
| GALMED PHARMACEUTICALS LTD. | Teknisk/Vetenskaplig/F&U Direktör | 2016-01-01 |
Michal Ayalons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Galmed Pharmaceuticals Ltd.
 Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Health Technology |
